Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/06/068922
CTRI/2024/06/068922
Not yet recruiting
Phase 4

Effect of topical recombinant human epidermal growth factor on wound healing in diabetic foot ulcers- randomised controlled trial - NI

Aarupadai veedu medical College and hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Aarupadai veedu medical College and hospital
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Aarupadai veedu medical College and hospital

Eligibility Criteria

Inclusion Criteria

  • •Diabetic foot ulcer patients

Exclusion Criteria

  • •Diabetic ulcer with gangrenous lesion and or involving underlying boneUncontrolled diabetes patients
  • •3\.Patient with hypersensitivity reactions to hEGF gel (redness, itching,Urticarial lesion, blebs)
  • •4\.Chronic non healing ulcers due to other etiologies

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Effect of topical recombinant human epidermal growth factor on chronic diabetic ulcer compared with conventional saline dressing
CTRI/2024/05/067239Dr A Sneha Daffodil
Completed
Not Applicable
The clinical benefit of topical moisturizers in xerosis patientDiseases of the skin and subcutaneous tissue
KCT0001508Samsung Medical Center80
Not yet recruiting
Phase 4
Healing of mouth soft tissues using topically applied gel.
CTRI/2023/01/049177OFFICE OF DGDS
Recruiting
Phase 3
The efficacy of topical recombinant human epidermal growth factor gel in combination with fractional radiofrequency microneedle in the treatment of mild to moderate atrophic acne scarmild to moderate rolling and shallow boxcar acne scars
TCTR20201201003none20
Completed
Not Applicable
Comparison of topical recombinant human epidermal growth factor versus aloe vera gel in combination with ablative 10,600-nm carbon dioxide fractional laser for the treatment of striae alba: A randomized, double-blind trialStriae albastriae alba&#44recombinant&#45human epidermal growth factor&#44fractional carbon dioxide laser
TCTR20180610001Thammasat University24